【24h】

Are healthcare economics a factor behind European MRSA rates?

机译:医疗保健经济学因素是否落后于欧洲MRSA率?

获取原文
获取原文并翻译 | 示例
       

摘要

This study assessed the relationship between meticillin-resistant Staphylococcus aureus (MRSA) prevalence in 26 European countries with two key socioeconomic parameters, namely, gross domestic product per capita (GDP) and infant mortality rate (IMR). Whilst no significant relationship was identified between MRSA and GDP (Spearman correlation: -0.387; 95% confidence interval [CI]: -0.674 to 0.000; p = 0.0528), a significant correlation was evident between MRSA and IMR (Spearman correlation: 0.545; 95% CI: 0.208 to 0.766; p = 0.005). The elimination of a widely outlying data point retained significance. Various studies have shown IMR to be a good marker of healthcare expenditure and it is, therefore, reasonable to postulate that one possible factor in the multi-factorial epidemiology of MRSA in Europe is the level and effectiveness of healthcare expenditure within the individual countries.
机译:这项研究评估了26个欧洲国家中耐甲氧西林金黄色葡萄球菌(MRSA)患病率与两个主要社会经济参数之间的关系,这些参数是人均国内生产总值(GDP)和婴儿死亡率(IMR)。尽管未发现MRSA与GDP之间存在显着相关性(Spearman相关性:-0.387; 95%置信区间[CI]:-0.674至0.000; p = 0.0528),但MRSA与IMR之间存在显着的相关性(Spearman相关性:0.545; Pearson相关性:0.545; P = 0.528)。 95%CI:0.208至0.766; p = 0.005)。消除广泛存在的数据点仍然具有重要意义。各种研究表明,IMR是医疗保健支出的良好标志,因此,有理由推测,在欧洲MRSA的多因素流行病学中,一个可能的因素是各个国家的医疗保健支出的水平和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号